Sara Flounders (2022-06-01). Demanding China's exclusion: U.S. blocks world access to vaccines. workers.org Just how far is the U.S. government determined to go in the protection of corporate profits? For the past two years the Biden administration and earlier the Trump administration have blocked every effort to make medicines for the COVID-19 virus widely available. U.S. control of the patents has been ruthlessly . . . |

WSWS (2022-06-01). The great unmentionable during the Ontario election campaign—the COVID-19 pandemic. wsws.org All of the parties are peddling the lie that the pandemic is over, and none has so much as attempted to seriously address its calamitous impact on a health care system already reeling from chronic underfunding.

WSWS (2022-06-01). Peruvian government uses "slight increase" in COVID numbers to extend state of emergency. wsws.org Peru's Health Ministry is minimizing the risk of another COVID wave while the government uses that risk to extend the state of emergency.

WSWS (2022-06-01). COVID-19 cases rise in the Mid-Atlantic as school districts refuse to impose any safety measures. wsws.org Despite rapid increases in COVID-19 infections, governments in the heavily-populated Mid-Atlantic region have largely refused to implement any measures to protect children in schools.

TeleSUR, JDO (2022-06-01). Shanghái levanta severo confinamiento tras brote de Covid-19. telesurtv.net La urbe de 25 millones de habitantes regresó a la normalidad. También lo hace la capital china, Beijing.

Katherine V. Houser, Martin R. Gaudinski, Myra Happe, Sandeep Narpala, Raffaello Verardi, Edward K. Sarfo, Angela R. Corrigan, Richard Wu, Ro Shauna Rothwell, Laura Novik, Cynthia S. Hendel, Ingelise J. Gordon, Nina M. Berkowitz, Cora Trelles Cartagena, Alicia T. Widge, Emily E. Coates, Larisa Strom, Somia Hickman, Michelle Conan-Cibotti, Sandra Vazquez, Olga Trofymenko, Sarah Plummer, Judy Stein, Christopher L. Case, Martha Nason, Andrea Biju, Danealle K. Parchment, Anita Changela, Cheng Cheng, Hongying Duan, Hui Geng, I-Ting Teng, Tongqing Zhou, Sarah O'Connell, Chris Barry, Kevin Carlton, Jason G. Gall, Britta Flach, Nicole A. Doria-Rose, Barney S. Graham, Richard A. Koup, Adrian B. McDermott, John R. Mascola, Peter D. Kwong, Julie E. Ledgerwood, VRC 018 Study Team (2022-06-01). [Articles] Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. thelancet.com Trimer 4571 was safe, well tolerated, and immunogenic in this first-in-human trial. While this phase 1 trial is limited in size, our results inform and support further evaluation of prefusion-stabilized HIV-1 envelope trimers as a component of vaccine design strategies to generate broadly neutralizing antibodies against HIV-1.